Long-term efficacy of infliximab in hidradenitis suppurativa

Treatment of Hidradenitis Suppurativa with Tumour Necrosis Factor-alpha Inhibitors: An Update on Infliximab

(2016) A Brunasso et al.   ACTA DERMATO-VENEREOLOGICA

A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa

(2011) I. Miller et al.   BRITISH JOURNAL OF DERMATOLOGY

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β

(2011) H.H. van der Zee et al.   BRITISH JOURNAL OF DERMATOLOGY

Tratamento de hidradenite supurativa com infliximab

(2010) Tiago Torres et al.   ANAIS BRASILEIROS DE DERMATOLOGIA

Efficacité de l’infliximab dans le traitement d’une triade d’occlusion folliculaire

(2010) M.-E. Deschamps et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Severe Refractory Hidradenitis Suppurativa in an HIV-Positive Patient Successfully Treated With Infliximab

(2010) Diana Alecsandru et al.   ARCHIVES OF DERMATOLOGY

Hidradenitis suppurativa responding to treatment with infliximab

(2010) Anita Lasocki et al.   AUSTRALASIAN JOURNAL OF DERMATOLOGY

Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial

(2010) Annika Grant et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease: attrition rate and evolution of disease activity

(2010) Bert Vander Cruyssen et al.   ARTHRITIS RESEARCH & THERAPY

Treatment of Hidradenitis Suppurativa with Tumour Necrosis Factor-alpha Inhibitors

(2009) P Haslund et al.   ACTA DERMATO-VENEREOLOGICA

Increased Serum Tumour Necrosis Factor- in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor- Agents?

(2009) L Matusiak et al.   ACTA DERMATO-VENEREOLOGICA

Hidradenitis suppurativa: are tumour necrosis factor-α blockers the ultimate alternative?

(2008) A.M.G. Brunasso et al.   BRITISH JOURNAL OF DERMATOLOGY